Complete Filing Data
Silexion Therapeutics Corp reported Stockholders Equity Including Portion Attributable To Noncontrolling Interest of $2.60 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Silexion Therapeutics Corp did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Net Income * | -$11.9M | -$16.5M | -$5.1M |
| Research And Development Expense | $7.1M | $5.8M | $3.7M |
| Operating Expenses | $11.6M | $12.6M | $4.7M |
| Net Income Loss Attributable To Noncontrolling Interest | $0.00 | $76.0K | $166.0K |
| General And Administrative Expense | $4.5M | $6.8M | $973.0K |
| Income Tax Expense Benefit | $3.0K | $10.0K | $32.0K |
| Operating Income Loss | -$11.6M | -$12.6M | -$4.7M |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$11.9M | -$16.5M | -$5.1M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|
| Net Income * | -$3.3M | -$2.5M | -$1.7M | -$11.9M | -$1.5M | -$1.4M | -$809.0K | -$1.9M |
| Research And Development Expense | $2.2M | $1.0M | $590.0K | $3.2M | $766.0K | $961.0K | $535.0K | $1.2M |
| Operating Expenses | $3.3M | $2.3M | $1.7M | $8.0M | $1.4M | $1.3M | $731.0K | $1.4M |
| Net Income Loss Attributable To Noncontrolling Interest | $0.00 | $0.00 | $0.00 | $9.0K | $17.0K | $50.0K | $22.0K | $223.0K |
| General And Administrative Expense | $1.1M | $1.3M | $1.1M | $4.8M | $619.0K | $289.0K | $196.0K | $179.0K |
| Income Tax Expense Benefit | $0.00 | $3.0K | $2.0K | $2.0K | $5.0K | $6.0K | $10.0K | |
| Operating Income Loss | -$3.3M | -$2.3M | -$8.0M | -$1.4M | -$731.0K | -$1.4M | ||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$3.3M | -$2.5M | -$1.7M | -$11.9M | -$1.5M | -$1.4M | -$803.0K | -$1.9M |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Stockholders Equity * | $2.6M | -$4.0M | -$15.5M | $7.6M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $6.1M | $1.3M | $4.6M | $8.3M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | $4.8M | -$3.3M | -$3.4M | |
| Equity Holders Of The Company | -$11.9M | -$16.4M | -$4.9M | |
| Restricted Cash | $84.0K | $83.0K | $50.0K | |
| Cash Equivalents At Carrying Value | $6.0M | $1.2M | $4.6M | |
| Assets | $7.2M | $2.9M | $5.3M | |
| Liabilities | $4.6M | $6.9M | $2.3M | |
| Cash And Cash Equivalents At Carrying Value | $6.0M | $1.2M | $4.6M | |
| Retained Earnings Accumulated Deficit | -$55.2M | -$43.3M | -$26.8M | |
| Restricted Cash Noncurrent | $57.0K | $48.0K | $25.0K | |
| Property Plant And Equipment Net | $25.0K | $30.0K | $49.0K | |
| Other Assets Current | $49.0K | $62.0K | $24.0K | |
| Other Accounts Payable And Accrued Liabilities | $910.0K | $788.0K | $1.4M | |
| Operating Lease Right Of Use Asset | $412.0K | $530.0K | $198.0K | |
| Operating Lease Liability Noncurrent | $286.0K | $368.0K | $59.0K | |
| Operating Lease Liability Current | $182.0K | $158.0K | $112.0K | |
| Liabilities Noncurrent | $1.9M | $3.3M | $59.0K | |
| Liabilities Current | $2.8M | $3.5M | $2.2M | |
| Liabilities And Stockholders Equity | $7.2M | $2.9M | $5.3M | |
| Gain Loss On Termination Of Lease | $0.00 | -$68.0K | $0.00 | |
| Employee Related Liabilities Current | $879.0K | $642.0K | $207.0K | |
| Deposits Assets Noncurrent | $84.0K | $5.0K | $5.0K | |
| Assets Noncurrent | $578.0K | $613.0K | $277.0K | |
| Assets Current | $6.6M | $2.3M | $5.0M | |
| Accounts Payable Current | $787.0K | $929.0K | $319.0K | |
| Restricted Cash And Cash Equivalents At Carrying Value | $27.0K | $35.0K | $25.0K | |
| Gain Loss On Sale Of Property Plant Equipment | $0.00 | -$16.0K | $1.0K | |
| Other Liabilities Current | $0.00 | $200.0K | ||
| Redeemable Noncontrolling Interest Equity Preferred Carrying Amount | $0.00 | $3.4M | ||
| Preferred Stock Redemption Amount | $0.00 | $18.5M | ||
| Operating Lease Termination | $0.00 | $89.0K | $0.00 | |
| Convertible Preferred Stock Nonredeemable Or Redeemable Issuer Option Value | $0.00 | $15.1M | ||
| Conversion Of Warrants To Preferred Shares On A Cashless Basis | 0.00 | 334.0K | 0.00 | |
| Cash Acquired In Excess Of Payments To Acquire Business | $0.00 | $2.3M | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity * | $7.0M | $120.0K | $2.6M | -$4.6M | -$18.3M | $1.6M | -$4.6M | $5.4M | $6.9M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $9.3M | $3.5M | $6.2M | $2.0M | $1.7M | $2.8M | $5.8M | $6.5M | $7.9M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | $5.8M | -$2.7M | $5.0M | $251.0K | -$1.1M | -$1.8M | -$613.0K | -$1.2M | |
| Equity Holders Of The Company | -$3.3M | -$2.5M | -$1.7M | -$11.9M | -$1.5M | -$1.4M | $787.0K | ||
| Restricted Cash | $81.0K | $78.0K | $81.0K | $50.0K | $50.0K | $50.0K | $48.0K | $49.0K | |
| Cash Equivalents At Carrying Value | $9.2M | $3.5M | $6.2M | $2.0M | $1.7M | $2.8M | $5.8M | ||
| Assets | $11.6M | $5.8M | $8.3M | $3.1M | $2.3M | $3.6M | |||
| Liabilities | $4.6M | $5.7M | $5.7M | $7.7M | $2.4M | ||||
| Cash And Cash Equivalents At Carrying Value | $9.2M | $3.5M | $6.2M | $2.0M | $1.7M | $6.4M | |||
| Retained Earnings Accumulated Deficit | -$50.8M | -$47.5M | -$45.0M | -$41.6M | -$29.7M | ||||
| Restricted Cash Noncurrent | $55.0K | $53.0K | $47.0K | $0.00 | $25.0K | ||||
| Property Plant And Equipment Net | $26.0K | $30.0K | $32.0K | $35.0K | $40.0K | ||||
| Other Assets Current | $47.0K | $63.0K | $58.0K | $80.0K | $66.0K | ||||
| Other Accounts Payable And Accrued Liabilities | $945.0K | $659.0K | $893.0K | $1.9M | $1.4M | ||||
| Operating Lease Right Of Use Asset | $442.0K | $472.0K | $502.0K | $0.00 | $140.0K | ||||
| Operating Lease Liability Noncurrent | $311.0K | $337.0K | $334.0K | $0.00 | $8.0K | ||||
| Operating Lease Liability Current | $174.0K | $171.0K | $155.0K | $0.00 | $108.0K | ||||
| Liabilities Noncurrent | $1.9M | $3.5M | $3.3M | $4.1M | $8.0K | ||||
| Liabilities Current | $2.8M | $2.2M | $2.4M | $3.6M | $2.4M | ||||
| Liabilities And Stockholders Equity | $11.6M | $5.8M | $8.3M | $3.1M | $2.5M | ||||
| Gain Loss On Termination Of Lease | $0.00 | -$68.0K | $0.00 | ||||||
| Employee Related Liabilities Current | $721.0K | $628.0K | $624.0K | $687.0K | $251.0K | ||||
| Deposits Assets Noncurrent | $36.0K | $5.0K | $5.0K | $5.0K | $5.0K | ||||
| Assets Noncurrent | $559.0K | $560.0K | $586.0K | $40.0K | $210.0K | ||||
| Assets Current | $11.1M | $5.2M | $7.7M | $3.0M | $2.3M | ||||
| Accounts Payable Current | $946.0K | $692.0K | $722.0K | $799.0K | $281.0K | ||||
| Restricted Cash And Cash Equivalents At Carrying Value | $26.0K | $25.0K | $34.0K | $50.0K | |||||
| Gain Loss On Sale Of Property Plant Equipment | $0.00 | $1.0K | |||||||
| Other Liabilities Current | $0.00 | $345.0K | |||||||
| Redeemable Noncontrolling Interest Equity Preferred Carrying Amount | $0.00 | $3.4M | |||||||
| Preferred Stock Redemption Amount | $0.00 | $18.4M | |||||||
| Operating Lease Termination | $0.00 | $55.0K | $0.00 | ||||||
| Convertible Preferred Stock Nonredeemable Or Redeemable Issuer Option Value | $0.00 | $15.1M | |||||||
| Conversion Of Warrants To Preferred Shares On A Cashless Basis | 0.00 | 334.0K | 0.00 | ||||||
| Cash Acquired In Excess Of Payments To Acquire Business | $0.00 | $2.3M | $0.00 |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Share Based Compensation | $134.0K | $5.9M | $130.0K |
| Net Cash Provided By Used In Operating Activities | -$10.8M | -$8.4M | -$4.5M |
| Increase Decrease In Prepaid Expense | -$396.0K | $631.0K | $329.0K |
| Increase Decrease In Operating Lease Liability | -$5.0K | -$57.0K | $6.0K |
| Increase Decrease In Employee Related Liabilities | $237.0K | $435.0K | -$46.0K |
| Increase Decrease In Accounts Payable Trade | -$142.0K | $610.0K | $79.0K |
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | -$2.0K | -$61.0K | -$230.0K |
| Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition | $134.0K | $5.9M | $130.0K |
| Payments To Acquire Property Plant And Equipment | $9.0K | $22.0K | $12.0K |
| Net Cash Provided By Used In Investing Activities | -$14.0K | -$22.0K | $573.0K |
| Net Cash Provided By Used In Financing Activities | $15.6M | $5.1M | $522.0K |
| Increase Decrease In Accrued Liabilities | $102.0K | -$1.9M | $359.0K |
| Proceeds From Stock Options Exercised | $0.00 | $3.1M | $0.00 |
| Proceeds From Issuance Of Preferred Stock And Preference Stock | $0.00 | $522.0K | |
| Proceeds From Sale Of Short Term Investments | $0.00 | $507.0K | |
| Increase Decrease In Accounts And Other Receivables | |||
| Proceeds From Sale Of Property Plant And Equipment | $0.00 | $78.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|
| Share Based Compensation | $38.0K | $37.0K | $21.0K | $5.8M | $32.0K | $32.0K | $32.0K | $32.0K |
| Net Cash Provided By Used In Operating Activities | -$2.8M | -$2.5M | -$2.5M | -$2.7M | -$1.1M | -$1.8M | -$685.0K | -$1.7M |
| Increase Decrease In Prepaid Expense | $56.0K | $205.0K | $512.0K | $417.0K | $63.0K | $129.0K | $198.0K | -$5.0K |
| Increase Decrease In Operating Lease Liability | -$2.0K | $2.0K | -$1.0K | -$44.0K | $2.0K | $2.0K | -$2.0K | -$2.0K |
| Increase Decrease In Employee Related Liabilities | $93.0K | $4.0K | -$18.0K | $436.0K | -$3.0K | $47.0K | -$13.0K | -$20.0K |
| Increase Decrease In Accounts Payable Trade | $254.0K | -$30.0K | -$207.0K | $517.0K | $37.0K | -$75.0K | $131.0K | -$52.0K |
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | -$1.0K | $14.0K | -$10.0K | $25.0K | -$19.0K | -$56.0K | -$66.0K | -$277.0K |
| Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition | $38.0K | $37.0K | $21.0K | $5.8M | $32.0K | $32.0K | $32.0K | $32.0K |
| Payments To Acquire Property Plant And Equipment | $0.00 | $1.0K | $6.0K | $16.0K | $0.00 | $6.0K | $6.0K | $2.0K |
| Net Cash Provided By Used In Investing Activities | $0.00 | -$1.0K | -$6.0K | -$16.0K | $0.00 | -$6.0K | $72.0K | -$2.0K |
| Net Cash Provided By Used In Financing Activities | $8.6M | -$195.0K | $7.4M | $2.9M | $0.00 | $0.00 | $522.0K | |
| Increase Decrease In Accrued Liabilities | -$90.0K | -$905.0K | $327.0K | -$306.0K | $33.0K | -$35.0K | ||
| Proceeds From Stock Options Exercised | $0.00 | $0.00 | $620.0K | $0.00 | $0.00 | |||
| Proceeds From Issuance Of Preferred Stock And Preference Stock | $0.00 | $0.00 | $522.0K | |||||
| Proceeds From Sale Of Short Term Investments | $0.00 | $0.00 | ||||||
| Increase Decrease In Accounts And Other Receivables | -$4.0K | $17.0K | -$2.0K | $44.0K | -$24.0K | $20.0K | ||
| Proceeds From Sale Of Property Plant And Equipment | $0.00 | $78.0K |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Weighted Average Number Of Shares Outstanding Basic | 1.3M | 41.6K | 111.7K |
| Weighted Average Number Of Diluted Shares Outstanding | 1.3M | 41.6K | 111.7K |
| Earnings Per Share Diluted | $8.96 | $394.94 | $44.23 |
| Earnings Per Share Basic | $8.96 | $394.94 | $44.23 |
| Common Stock Par Or Stated Value Per Share | $0.01 | $0.01 | $0.00 |
| Common Stock Shares Outstanding | 3.13B | 123.3M | 97.1M |
| Common Stock Shares Issued | 3.13B | 123.3M | 97.1M |
| Common Stock Shares Authorized | 9.00B | 1.48B | 22.22B |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|
| Weighted Average Number Of Shares Outstanding Basic | 1.1M | 579.5K | 6.8M | 43.2K | 7.4K | 111.7K | 1.0M | 252.5K |
| Weighted Average Number Of Diluted Shares Outstanding | 1.1M | 579.5K | 6.8M | 43.2K | 7.4K | 111.7K | 1.0M | 252.5K |
| Earnings Per Share Diluted | $2.88 | $4.32 | $0.26 | $274.25 | $197.80 | $12.29 | $0.78 | $6.54 |
| Earnings Per Share Basic | $2.88 | $4.32 | $0.26 | $274.25 | $197.80 | $12.29 | $0.78 | $6.54 |
| Common Stock Par Or Stated Value Per Share | $0.01 | $0.01 | $0.00 | $0.00 | $0.01 | |||
| Common Stock Shares Outstanding | 3.1M | 579.5K | 8.7M | 11.2M | 219.4K | |||
| Common Stock Shares Issued | 3.1M | 579.5K | 8.7M | 11.2M | 250.5K | |||
| Common Stock Shares Authorized | 9.0M | 1.5M | 22.2M | 200.0M | 3.3M |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Interest Paid Net | $13.0K | $27.0K | $0.00 |
| Financial Expenses | $277.0K | $3.9M | $395.0K |
| Depreciation | $14.0K | $25.0K | $45.0K |
| Other Noncash Expense | |||
| Additional Paid In Capital | $57.7M | $39.3M | $11.3M |
| Prepaid Expense Current | $570.0K | $966.0K | $335.0K |
| Stock Issued During Period Value New Issues | $412.0K | ||
| Conversion Of Preferred Shares | 0.00 | 15.4M | 0.00 |
| Interest Income Other | $155.0K | $28.0K | $153.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|
| Interest Paid Net | $0.00 | $0.00 | $13.0K | $0.00 | $0.00 | $0.00 | $42.0K | $39.0K |
| Financial Expenses | -$30.0K | $216.0K | $85.0K | $3.8M | $102.0K | $168.0K | $72.0K | $452.0K |
| Depreciation | $4.0K | $3.0K | $4.0K | $22.0K | $7.0K | $8.0K | $10.0K | $14.0K |
| Other Noncash Expense | $229.0K | $81.0K | $3.7M | $83.0K | $136.0K | $108.0K | $278.0K | |
| Additional Paid In Capital | $57.7M | $47.6M | $47.6M | $37.0M | $11.4M | |||
| Prepaid Expense Current | $1.7M | $1.7M | $1.5M | $944.0K | $527.0K | |||
| Stock Issued During Period Value New Issues | $412.0K | |||||||
| Conversion Of Preferred Shares | 0.00 | 15.1M | 0.00 | |||||
| Interest Income Other | $40.0K | $44.0K | $2.0K | $0.00 | $6.0K | $19.0K |
Most recent annual filing with the SEC: March 17, 2026
Data sourced from SEC EDGAR public filings as of August 5, 2026.